Personalized pulmonary vein isolation with very high-power short-duration lesions guided by left atrial wall thickness: the QDOT-by-LAWT randomized trial.
Falasconi G, Penela D, Soto-Iglesias D, Francia P, Saglietto A, Turturiello D, Viveros D, Bellido A, Alderete J, Zaraket F, Franco-Ocaña P, Huguet M, Cámara Ó, Vătășescu R, Ortiz-Pérez JT, Martí-Almor J, Berruezo A.
Falasconi G, et al. Among authors: bellido a.
Europace. 2024 Mar 30;26(4):euae087. doi: 10.1093/europace/euae087.
Europace. 2024.
PMID: 38652090
Free PMC article.
Clinical Trial.